SLC5A2 and myocardial infarction: Moreover, these favorable effects of SGLT2 inhibitors were also found in the secondary prevention of nonfatal myocardial infarction in a subanalysis of the CANVAS Program [12] and in the primary prevention of HHF in a subanalysis of DECLARE-TIMI 58 [13].